ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
비경구 영양 시장 규모는 2025년 87억 4,000만 달러에서 2026년부터 2034년까지 CAGR 6.65%로 성장하여 2034년에는 155억 9,000만 달러에 달할 것으로 예측됩니다.
비경구 영양 시장은 만성질환의 증가와 영양 지원이 필요한 환자 수의 증가를 배경으로 큰 폭의 성장이 예상됩니다. 의료진이 환자의 치료 결과를 개선하는 데 있어 적절한 영양 섭취의 중요성을 인식함에 따라 비경구 영양 솔루션에 대한 수요가 증가할 것으로 예상됩니다. 이 시장은 아미노산, 지질, 탄수화물, 비타민 등 경구 섭취가 어려운 환자의 특정 영양 요구를 충족시키기 위해 다양한 제품군을 포괄하고 있습니다. 회복과 질병 관리에서 영양의 역할에 대한 인식이 높아지면서 다양한 의료 현장에서 비경구 영양의 도입이 촉진되고 있습니다.
또한, 비경구 영양제 및 투여 시스템의 혁신도 이 시장의 미래를 형성하고 있습니다. 대사 상태, 동반 질환 등 환자 개개인의 요구사항을 고려한 맞춤형 영양 솔루션의 개발로 비경구 영양의 효과가 높아지고 있습니다. 또한, 스마트 펌프와 자동화 시스템을 포함한 수액 기술의 발전으로 영양 공급의 안전성과 정확성이 향상되어 비경구 영양 공급과 관련된 합병증의 위험이 감소하고 있습니다. 이러한 기술이 계속 발전함에 따라, 다양한 환자군을 위한 제품 라인업의 다양화가 시장에서 진행될 것으로 예상됩니다.
또한, 의료 기관과 제약 회사가 영양 지원에 대한 미충족 수요를 인식함에 따라 R&D에 대한 투자 증가는 비경구 영양 시장에 긍정적인 영향을 미칠 것입니다. 임상의, 영양사, 이해관계자 간의 협력은 임상 가이드라인을 추진하고 비경구 영양의 안전하고 효과적인 사용을 보장하는 데 매우 중요합니다. 변화하는 환경 속에서 규제 당국은 혁신적 제제의 승인 절차를 간소화하고 생명을 구하는 영양 요법에 대한 신속한 접근을 촉진할 것으로 기대됩니다. 비경구 영양을 종합적인 환자 치료 전략에 통합하는 데 점점 더 초점을 맞추고, 회복과 전반적인 건강 상태 개선에 있어 영양의 중요성이 강조될 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 비경구 영양 시장 : 영양소 유형별
제5장 세계의 비경구 영양 시장 : 스테이지 유형별
제6장 세계의 비경구 영양 시장 : 적응증별
제7장 세계의 비경구 영양 시장 : 세일즈 채널별
제8장 세계의 비경구 영양 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSM
영문 목차
영문목차
The Parenteral Nutrition Market size is expected to reach USD 15.59 Billion in 2034 from USD 8.74 Billion (2025) growing at a CAGR of 6.65% during 2026-2034.
The parenteral nutrition market is set for significant growth, driven by the increasing prevalence of chronic diseases and the rising number of patients requiring nutritional support. As healthcare providers recognize the importance of adequate nutrition in improving patient outcomes, the demand for parenteral nutrition solutions is expected to rise. This market encompasses a range of products, including amino acids, lipids, carbohydrates, and vitamins, tailored to meet the specific nutritional needs of patients unable to consume food orally. The growing awareness of the role of nutrition in recovery and disease management is propelling the adoption of parenteral nutrition across various healthcare settings.
Innovations in parenteral nutrition formulations and delivery systems are also shaping the future of this market. The development of customized nutrition solutions that consider individual patient requirements, such as metabolic conditions and comorbidities, is enhancing the effectiveness of parenteral nutrition. Additionally, advancements in infusion technology, including smart pumps and automated systems, are improving the safety and accuracy of nutrient delivery, reducing the risk of complications associated with parenteral feeding. As these technologies continue to evolve, the market is likely to witness a diversification of product offerings that cater to a wide range of patient populations.
Furthermore, the parenteral nutrition market will benefit from increased investment in research and development, as healthcare organizations and pharmaceutical companies recognize the unmet needs in nutritional support. Collaborative efforts between clinicians, nutritionists, and industry stakeholders will be crucial in advancing clinical guidelines and ensuring the safe and effective use of parenteral nutrition. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative formulations, facilitating faster access to life-saving nutritional therapies. The focus will increasingly shift towards integrating parenteral nutrition into comprehensive patient care strategies, emphasizing the importance of nutrition in enhancing recovery and overall health outcomes.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Nutrient Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals
By A Stage Type
Adult
Pediatrics
By Indication
Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
ByA Sales Channel
Online
Retail
Institutional
COMPANIES PROFILED
Baxter, Grifols, Allergan, Otsuka Pharmaceutical Factory Inc, Actavis Inc, B Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co Ltd, Pfizer Inc Hospira Inc
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL PARENTERAL NUTRITION MARKET: BY NUTRIENT TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Nutrient Type
4.2. Carbohydrates Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Parenteral Lipid Emulsion Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Single Dose Amino Acid Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Trace Elements Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Vitamins & Minerals Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL PARENTERAL NUTRITION MARKET: BY STAGE TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Stage Type
5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL PARENTERAL NUTRITION MARKET: BY INDICATION 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Indication
6.2. Alzheimer's Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Nutrition Deficiency Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Cancer Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Chronic Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.7. Orphan Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.8. Dysphagia Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.9. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.10. Malabsorption/GI Disorder/Diarrhea Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL PARENTERAL NUTRITION MARKET: BY SALES CHANNEL 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast Sales Channel
7.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Institutional Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL PARENTERAL NUTRITION MARKET: BY REGION 2022-2034(USD MN)
8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.2.1 By Nutrient Type
8.2.2 By Stage Type
8.2.3 By Indication
8.2.4 By Sales Channel
8.2.5 United States
8.2.6 Canada
8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.3.1 By Nutrient Type
8.3.2 By Stage Type
8.3.3 By Indication
8.3.4 By Sales Channel
8.3.5 United Kingdom
8.3.6 France
8.3.7 Germany
8.3.8 Italy
8.3.9 Russia
8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.4.1 By Nutrient Type
8.4.2 By Stage Type
8.4.3 By Indication
8.4.4 By Sales Channel
8.4.5 India
8.4.6 Japan
8.4.7 South Korea
8.4.8 Australia
8.4.9 South East Asia
8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.5.1 By Nutrient Type
8.5.2 By Stage Type
8.5.3 By Indication
8.5.4 By Sales Channel
8.5.5 Brazil
8.5.6 Argentina
8.5.7 Peru
8.5.8 Chile
8.5.9 South East Asia
8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.6.1 By Nutrient Type
8.6.2 By Stage Type
8.6.3 By Indication
8.6.4 By Sales Channel
8.6.5 Saudi Arabia
8.6.6 UAE
8.6.7 Israel
8.6.8 South Africa
8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL PARENTERAL NUTRITION INDUSTRY
